This trial aims to investigate the safety and effectiveness of the patient's own bone marrow stem cells for end stage liver diseases. The trial is being conducted by the 105th PLA Hospital in Anhui Province and plans to enrol 100 patients with end stage liver failure. The subjects will be administered an intravenous (IV) infusion of their own bone marrow derived stem cells. Participants will be monitored for complications and for makers of liver failure. The trial commenced in February 2012.